Antje Dittmann

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

Mark A. Dawson, Rab K. Prinjha, Antje Dittmann et al. · Nature · 2011 · 1.5K citations · Full text

Life Sciences, Hematology, Molecular Biology +10

Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes

Marcus Bantscheff, Carsten Hopf, Mikhail M. Savitski et al. · Nature Biotechnology · 2011 · 666 citations

Pharmacy, Medicinal Chemistry, Pharmacology +9

Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition

Natalie H. Theodoulou, Paul Bamborough, Andrew J. Bannister et al. · Journal of Medicinal Chemistry · 2015 · 234 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia

Mark A. Dawson, Emma Gudgin, Sarah J. Horton et al. · Leukemia · 2013 · 175 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Optimized Chemical Proteomics Assay for Kinase Inhibitor Profiling

Guillaume Médard, Fiona Pachl, Benjamin Ruprecht et al. · Journal of Proteome Research · 2015 · 136 citations

Medicine, Medicinal Chemistry, Pharmacology +16